Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8519 |
High Similarity |
NPD3027 |
Phase 3 |
0.8333 |
Intermediate Similarity |
NPD1613 |
Approved |
0.8333 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8235 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.8203 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.8125 |
Intermediate Similarity |
NPD7843 |
Approved |
0.8077 |
Intermediate Similarity |
NPD7157 |
Approved |
0.8071 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.8071 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.8043 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.8043 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8014 |
Intermediate Similarity |
NPD5735 |
Approved |
0.8 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7971 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7929 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7926 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7883 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7843 |
Intermediate Similarity |
NPD37 |
Approved |
0.7834 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7812 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7806 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7806 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7806 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7785 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7778 |
Intermediate Similarity |
NPD6516 |
Phase 2 |
0.7778 |
Intermediate Similarity |
NPD5846 |
Approved |
0.7769 |
Intermediate Similarity |
NPD228 |
Approved |
0.7755 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.773 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7724 |
Intermediate Similarity |
NPD5588 |
Approved |
0.7722 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7707 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7704 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7703 |
Intermediate Similarity |
NPD6331 |
Phase 2 |
0.7692 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7681 |
Intermediate Similarity |
NPD5327 |
Phase 3 |
0.7664 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7655 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7655 |
Intermediate Similarity |
NPD4538 |
Approved |
0.7655 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7643 |
Intermediate Similarity |
NPD6584 |
Phase 3 |
0.7639 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7635 |
Intermediate Similarity |
NPD4237 |
Approved |
0.7635 |
Intermediate Similarity |
NPD4236 |
Phase 3 |
0.7625 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7619 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7619 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7619 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7615 |
Intermediate Similarity |
NPD3021 |
Approved |
0.7615 |
Intermediate Similarity |
NPD3022 |
Approved |
0.76 |
Intermediate Similarity |
NPD5058 |
Phase 3 |
0.7593 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7584 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7584 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7578 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7578 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7578 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7569 |
Intermediate Similarity |
NPD4140 |
Approved |
0.7569 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.7569 |
Intermediate Similarity |
NPD5837 |
Clinical (unspecified phase) |
0.7554 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7554 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7554 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7552 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7516 |
Intermediate Similarity |
NPD6374 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD1375 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD1934 |
Approved |
0.75 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7483 |
Intermediate Similarity |
NPD5960 |
Phase 3 |
0.7482 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7468 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7467 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7466 |
Intermediate Similarity |
NPD6353 |
Approved |
0.7466 |
Intermediate Similarity |
NPD6653 |
Approved |
0.7465 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7453 |
Intermediate Similarity |
NPD3051 |
Approved |
0.7452 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7452 |
Intermediate Similarity |
NPD5772 |
Approved |
0.7452 |
Intermediate Similarity |
NPD6818 |
Clinical (unspecified phase) |
0.7452 |
Intermediate Similarity |
NPD5773 |
Approved |
0.7432 |
Intermediate Similarity |
NPD2161 |
Phase 2 |
0.7431 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7429 |
Intermediate Similarity |
NPD6582 |
Phase 2 |
0.7429 |
Intermediate Similarity |
NPD6583 |
Phase 3 |
0.7419 |
Intermediate Similarity |
NPD6055 |
Clinical (unspecified phase) |
0.7417 |
Intermediate Similarity |
NPD2677 |
Approved |
0.7415 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7413 |
Intermediate Similarity |
NPD5752 |
Clinical (unspecified phase) |
0.741 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7407 |
Intermediate Similarity |
NPD2969 |
Approved |
0.7407 |
Intermediate Similarity |
NPD2970 |
Approved |
0.7407 |
Intermediate Similarity |
NPD6671 |
Approved |
0.74 |
Intermediate Similarity |
NPD4162 |
Approved |
0.74 |
Intermediate Similarity |
NPD3060 |
Approved |
0.7397 |
Intermediate Similarity |
NPD3657 |
Discovery |
0.7386 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7386 |
Intermediate Similarity |
NPD4123 |
Phase 3 |
0.7378 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7372 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7365 |
Intermediate Similarity |
NPD6028 |
Clinical (unspecified phase) |
0.7365 |
Intermediate Similarity |
NPD6029 |
Clinical (unspecified phase) |
0.7357 |
Intermediate Similarity |
NPD2231 |
Phase 2 |
0.7357 |
Intermediate Similarity |
NPD2235 |
Phase 2 |
0.7355 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7351 |
Intermediate Similarity |
NPD6658 |
Clinical (unspecified phase) |
0.7342 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7338 |
Intermediate Similarity |
NPD7527 |
Clinical (unspecified phase) |
0.7338 |
Intermediate Similarity |
NPD52 |
Approved |
0.7338 |
Intermediate Similarity |
NPD5261 |
Clinical (unspecified phase) |
0.7338 |
Intermediate Similarity |
NPD7526 |
Approved |
0.7337 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD7037 |
Approved |
0.7333 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7328 |
Intermediate Similarity |
NPD290 |
Approved |
0.7324 |
Intermediate Similarity |
NPD3094 |
Phase 2 |
0.7313 |
Intermediate Similarity |
NPD5535 |
Approved |
0.7312 |
Intermediate Similarity |
NPD7831 |
Phase 2 |
0.7312 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7312 |
Intermediate Similarity |
NPD7832 |
Clinical (unspecified phase) |
0.7312 |
Intermediate Similarity |
NPD7833 |
Phase 2 |
0.7305 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.7305 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7305 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7303 |
Intermediate Similarity |
NPD5241 |
Discontinued |
0.7299 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7296 |
Intermediate Similarity |
NPD2560 |
Approved |
0.7296 |
Intermediate Similarity |
NPD2563 |
Approved |
0.7289 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7286 |
Intermediate Similarity |
NPD3092 |
Approved |
0.7285 |
Intermediate Similarity |
NPD5177 |
Phase 3 |
0.7267 |
Intermediate Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.726 |
Intermediate Similarity |
NPD1726 |
Clinical (unspecified phase) |
0.7256 |
Intermediate Similarity |
NPD27 |
Approved |
0.7256 |
Intermediate Similarity |
NPD2489 |
Approved |
0.7254 |
Intermediate Similarity |
NPD6696 |
Suspended |
0.7252 |
Intermediate Similarity |
NPD968 |
Approved |
0.7251 |
Intermediate Similarity |
NPD7906 |
Approved |
0.725 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7244 |
Intermediate Similarity |
NPD3686 |
Approved |
0.7244 |
Intermediate Similarity |
NPD3687 |
Approved |
0.7241 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7239 |
Intermediate Similarity |
NPD6071 |
Discontinued |
0.7234 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7233 |
Intermediate Similarity |
NPD2977 |
Approved |
0.7233 |
Intermediate Similarity |
NPD2978 |
Approved |
0.7233 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7229 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7222 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7218 |
Intermediate Similarity |
NPD5451 |
Approved |
0.7211 |
Intermediate Similarity |
NPD2238 |
Phase 2 |
0.7209 |
Intermediate Similarity |
NPD291 |
Approved |
0.7202 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7194 |
Intermediate Similarity |
NPD6830 |
Clinical (unspecified phase) |
0.7192 |
Intermediate Similarity |
NPD5110 |
Phase 2 |
0.7192 |
Intermediate Similarity |
NPD5109 |
Approved |
0.7192 |
Intermediate Similarity |
NPD5111 |
Phase 2 |
0.719 |
Intermediate Similarity |
NPD6190 |
Approved |
0.719 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.7188 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7188 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7186 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7179 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.717 |
Intermediate Similarity |
NPD7945 |
Clinical (unspecified phase) |
0.7162 |
Intermediate Similarity |
NPD4340 |
Discontinued |
0.7161 |
Intermediate Similarity |
NPD7446 |
Clinical (unspecified phase) |
0.716 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7153 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7153 |
Intermediate Similarity |
NPD4624 |
Approved |
0.7152 |
Intermediate Similarity |
NPD4678 |
Approved |
0.7152 |
Intermediate Similarity |
NPD4675 |
Approved |
0.7143 |
Intermediate Similarity |
NPD6815 |
Approved |
0.7143 |
Intermediate Similarity |
NPD5126 |
Approved |
0.7143 |
Intermediate Similarity |
NPD5125 |
Phase 3 |
0.7143 |
Intermediate Similarity |
NPD7265 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7134 |
Intermediate Similarity |
NPD4210 |
Discontinued |
0.7133 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7124 |
Intermediate Similarity |
NPD4535 |
Phase 3 |
0.7124 |
Intermediate Similarity |
NPD7466 |
Approved |
0.7122 |
Intermediate Similarity |
NPD7741 |
Discontinued |
0.7122 |
Intermediate Similarity |
NPD3091 |
Approved |
0.7122 |
Intermediate Similarity |
NPD6580 |
Approved |
0.7122 |
Intermediate Similarity |
NPD1182 |
Approved |
0.7122 |
Intermediate Similarity |
NPD6581 |
Approved |
0.7118 |
Intermediate Similarity |
NPD7311 |
Approved |
0.7118 |
Intermediate Similarity |
NPD7313 |
Approved |
0.7118 |
Intermediate Similarity |
NPD7310 |
Approved |
0.7118 |
Intermediate Similarity |
NPD7312 |
Approved |
0.7113 |
Intermediate Similarity |
NPD1840 |
Phase 2 |
0.7108 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7097 |
Intermediate Similarity |
NPD1774 |
Approved |
0.7093 |
Intermediate Similarity |
NPD4663 |
Approved |
0.7089 |
Intermediate Similarity |
NPD4005 |
Discontinued |
0.7076 |
Intermediate Similarity |
NPD7309 |
Approved |
0.7075 |
Intermediate Similarity |
NPD6812 |
Clinical (unspecified phase) |
0.7075 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7071 |
Intermediate Similarity |
NPD5585 |
Approved |
0.707 |
Intermediate Similarity |
NPD2122 |
Discontinued |
0.7067 |
Intermediate Similarity |
NPD6895 |
Approved |
0.7067
|
Intermediate Similarity |
NPD6896 |
Approved |